Staff, students join hands outside LSTM to mark World Malaria Day

NewsGuard 100/100 Score

One hundred staff and students joined hands outside Liverpool School of Tropical Medicine (LSTM) today to mark World Malaria Day, each person symbolising 10,000 of the lives lost every year to malaria.

Professor Steve Ward, Deputy Director of LSTM, led the event and explained:

"Malaria kills one million people every year, more than any other parasitic infection.  Most deaths are in Africa and mostly in children under five years old.

"World Malaria Day is held every year to remind the global community that the disease is preventable and treatable but that much more needs to be done to stop children dying needlessly.  On average, one child dies every 30 seconds from malaria.

"LSTM has been researching ways to combat malaria for more than 100 years and that fight continues today with more than 50 projects active against malaria and malaria in pregnancy.  We're working with organisations in over 30 countries around the world to develop better and cheaper drugs to prevent and treat malaria and better ways of combating the mosquitoes which transmit the disease.

"World Malaria Day is being held this year on Sunday 25 April.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New malaria vaccine strain shows promise in preclinical trials